Skip to main content

Some major asthma inhaler manufacturers announced $35 a month caps on out-of-pocket costs. The price cap will apply to people with commercial/private insurance (through your job or federal or state marketplace) or no insurance.

If you have government-funded insurance (such as Medicare, Medicaid, or Tricare), you won’t qualify for a price cap, but you may qualify for a patient assistance program that can reduce what you pay.

The inhalers that will be price capped include:

AstraZeneca (effective June 1, 2024):

  • AIRSUPRA® (albuterol and budesonide) inhalation aerosol
  • BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) inhalation aerosol
  • BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol
  • SYMBICORT® (budesonide and formoterol fumarate dihydrate) inhalation aerosol

How you can save on AstraZeneca inhalers:

If you have commercial insurance: You can pay as little as $0 for AIRSUPRA and BREZTRI and pay no more than $35 for SYMBICORT and BEVESPI using a savings card. 

Savings cards:

If you have commercial insurance but AstraZeneca inhalers are not covered in your plan: You or your health care providers can ask for prior authorization. Or you can ask your doctor about trying another inhaler option. 

If you don’t have insurance: You can use the $35 savings card for people without insurance. Visit the AZ&ME US Patient Support site to access the card 

If you have government-funded insurance: Visit AZ&Me. They will decide if you qualify based on where you live, insurance status, and income.

For more information, visit AstraZeneca’s patient support site or call 1-800-236-9933.



Boehringer Ingelheim (effective June 1, 2024):

  • Atrovent® HFA (ipratropium bromide HFA) inhalation aerosol
  • Combivent® Respimat® (ipratropium bromide and albuterol) inhalation spray
  • Spiriva® HandiHaler® (tiotropium bromide) inhalation powder
  • Spiriva® Respimat® 1.25 mcg (tiotropium bromide) inhalation spray
  • Spiriva® Respimat® 2.5 mcg (tiotropium bromide) inhalation spray
  • Stiolto® Respimat® (tiotropium bromide and olodaterol) inhalation spray
  • Striverdi® Respimat® (olodaterol) inhalation spray

How you can save on Boehringer Ingelheim inhalers:

If you have commercial insurance: If you qualify, your cost will automatically be discounted when you buy these inhalers at participating retail pharmacies. If your cost is more than $35, visit InhalerOffer.com to download a savings card.

If you don’t have insurance, are on government insurance, or your pharmacy isn’t participating in this program: Visit InhalerOffer.com to get a savings card. Give this card to your pharmacy to get the $35 cap.



GSK (Effective beginning Jan. 1, 2025):

  • Advair Diskus (fluticasone propionate and salmeterol inhalation powder)
  • Advair HFA (fluticasone propionate and salmeterol inhalation aerosol)
  • Anoro Ellipta (umeclidinium and vilanterol inhalation powder)
  • Arnuity Ellipta (fluticasone furoate inhalation powder)
  • Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
  • Incruse Ellipta (umeclidinium inhalation powder)
  • Serevent Diskus (salmeterol xinafoate inhalation powder)
  • Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)
  • Ventolin HFA (albuterol sulfate inhalation aerosol)

How to save on GSK inhalers:

If you have commercial insurance or no insurance: Download the GSK “Pay No More Than $35” coupon and give it to your pharmacist.

If you have government-funded insurance, such as Medicare, Medicaid, or Tricare: You may qualify for the GSK Patient Assistance Program for Anoro Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta, Serevent Diskus, and Trelegy Ellipta. Visit the GSK Patient Assistance Program webpage to see if you qualify.


Other Ways to Save on Asthma Medicine

For other ways to save on asthma medicine, see our guide, "What to Do If You Can't Afford Your Asthma Medicine," and the GoodRx Asthma Inhaler Savings Guide.



Stay in the loop - get news and advocacy updates straight to your inbox with our e-newsletters.

SIGN ME UP FOR UPDATES!

Add Comment

Comments (0)

×
×
×
Link copied to your clipboard.
×